Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-13

FDA Approved: ALPRAZOLAM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for alprazolam from Mylan Pharmaceuticals Inc., indicating a revised or expanded approval under an NDA supplement. The a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)